10/18/2010

John Wolfe, a patient with lymphoma mantle cell B, is the first one in Portneuf Medical Center and in the southeastern Idaho area to be treated with Zevalin, a drug that accurately zeroes in and tags cancer cells. Doctors at the medical center said months of treatment with the drug has allowed Wolfe to begin recovering. The center is thinking about using the drug to treat more patients.

Related Summaries